Hangzhou Tigermed Consulting Co., Ltd.
Hangzhou Tigermed Consulting Co., Ltd.
Action · CNE100001KV8 (XSHE)
Aperçu
Pas de cours
Cours de clôture XSHE 22.10.2025: 53,22 CNY
22.10.2025 07:04
1 jour
-
1 semaine
-
1 mois
-
3 mois
-
6 mois
-
Année à ce jour
-
1 an
-
2 ans
-
3 ans
-
4 ans
-
5 ans
-
10 ans
-
20 ans
-
Max
-
Cours actuels de Hangzhou Tigermed Consulting Co., Ltd.
BourseTickerDeviseDernier échangeCoursVariation journalière
XSHE: SHENZHEN STOCK EXCHANGE
SHENZHEN STOCK EXCHANGE
300347.SZ
CNY
22.10.2025 07:04
53,22 CNY
-0,48 CNY
-0,89 %
Flottant et Liquidité des Actions
Flottant Libre 81,35 %
Actions en Flottant 600,27 M
Actions en Circulation 737,9 M
Fonds investis

Les fonds suivants ont investi dans Hangzhou Tigermed Consulting Co., Ltd. :

Fonds
iShares MSCI China UCITS ETF USD (Dist)
Vol. en millions
0,69
Part (%)
0,02 %
Fonds
iShares MSCI EM ESG Enhanced UCITS ETF USD (Dist)
Vol. en millions
40,02
Part (%)
0,01 %
Fonds
iShares MSCI EM ESG Enhanced UCITS ETF USD (Acc)
Vol. en millions
168,53
Part (%)
0,01 %
Fonds
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)
Vol. en millions
14,24
Part (%)
0,0046 %
Fonds
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc)
Vol. en millions
72,09
Part (%)
0,0046 %
Profil de l'entreprise pour Hangzhou Tigermed Consulting Co., Ltd. Action
Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system. It also provides biometrics services comprising data management, biostatistics, and statistical programming; and integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital. Further, the company offers medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value-added services; and post-marketing study, real world evidence, and vaccine clinical trial services. Hangzhou Tigermed Consulting Co., Ltd. was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.

Données de l'entreprise

Nom Hangzhou Tigermed Consulting Co., Ltd.
Société Hangzhou Tigermed Consulting Co., Ltd.
Site web https://www.tigermed.net
Marché d'origine XSHE SHENZHEN STOCK EXCHANGE
ISIN CNE100001KV8
Type de titre Action
Secteur Healthcare
Industrie Medical - Diagnostics & Research
PDG Xiaoping Ye D.Phil, EMBA,
Capitalisation boursière 52 Mrd.
Pays Chine
Devise CNY
Employés 10,2 T
Adresse F18, Building A – Shengda Science Park, 310051 Hangzhou
Date d'introduction en bourse 2012-08-17

Symboles boursiers

Nom Symbole
SHENZHEN STOCK EXCHANGE 300347.SZ
Autres actions
Les investisseurs qui détiennent Hangzhou Tigermed Consulting Co., Ltd. ont également les actions suivantes dans leur portefeuille :
ARCH.DANIELS 21/51
ARCH.DANIELS 21/51 Obligation
LBBW STUFENZINS 19/27
LBBW STUFENZINS 19/27 Obligation
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025